Q Liu, L Sun, Y Tan, G Wang, X Lin, L … - Current medicinal …, 2009 - ingentaconnect.com 1 Departments of Medicine, Radiation Oncology, and Pharmacology and Toxicology, the University
of Louisville, Louis- ville, USA; 2 Key Laboratory of Nutrition and Metabolism, Institute for Nutritional
Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and ... Cited by 2 - Related articles - All 3 versions
E Aigner, C Datz, C Datz - hepmon.com Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the insulin resistance
syndrome and thus a frequent cause of elevated liver enzymes. The term "insulin-resistance
associated hepatic iron overload syndrome (IR-HIOS)" has been coined to describe the ... Related articles - Cached - All 2 versions
E Aigner, C Datz - Hepatitis Monthly, 2008 - sid.ir Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the insulin- resistance
syndrome (also known as the metabolic syndrome) and a frequent cause of elevated liver enzymes
worldwide (1, 2). The prevalence of NAFLD and other manifestations of insulin resistance ... Related articles - View as HTML - All 5 versions